Trial · NCT03803124
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Renal plasma flow (RPF) | Two hours after trial medicine intake | Estimated by posterior Technetium-99m diethylenetriamine penta-acetic acid (99-mTc-DTPA) renography 2 hours after trial medicine intake. (unit of measurement= ml/min) |
| Secondary | Central and brachial blood pressures (BP) | Measured every 15 minutes during the examination day | Measured using Mobil-O-Graph® PWA (unit of measurement= mmHg) |
| Secondary | Glomerular filtration rate (GFR) | Two hours after trial medicine intake | Estimated by posterior Technetium-99m diethylenetriamine penta-acetic acid (99-mTc-DTPA) renography 2 hours after trial medicine intake. (unit of measurement= ml/min) |
| Secondary | Filtration fraction (FF) | Two hours after trial medicine intake | Estimated by posterior Technetium-99m diethylenetriamine penta-acetic acid (99-mTc-DTPA) renography 2 hours after trial medicine intake. (unit of measurement= %) |
| Secondary | Plasma concentration of vasopressin (p-AVP) | Measured before and 3 hours after trial medicine intake | Blood samples (unit of measurement= pg/ml) |
| Secondary | Plasma concentration of aldosterone (p-Aldo) | Measured before and 3 hours after trial medicine intake | Blood samples (unit of measurement= pmol/ml) |
| Secondary | Plasma concentration of angiotensin II (p-AngII) | Measured before and 3 hours after trial medicine intake | Blood samples (unit of measurement= pg/ml) |
| Secondary | Plasma concentration of renin (PRC) | Measured before and 3 hours after trial medicine intake | Blood samples (unit of measurement= pg/ml) |
| Secondary | Urine excretion of aquaporin 2 (u-AQP2) | Measured before and 3 hours after trial medicine intake | Urine sample (unit of measurement= ng/ml) |
| Secondary | Urine output (OU) | Measured before and 3 hours after trial medicine intake | Urine sample (unit of measurement= ml/min) |
| Secondary | Urine osmolality (U-osm) | measured before and 3 hours after trial medicine intake | Urine sample (unit of measurement= mosmol/kg) |
| Secondary | Fractional excretion of sodium (FENa) | Measured before and 3 hours after trial medicine intake | Blood and urine sample (unit of measurement= %) |
| Secondary | Albumin excretion rate | Measured before and 3 hours after trial medicine intake | Blood and urine sample (unit of measurement= mg/min) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03803124/registered